Paolo Boffetta

File:9-11 Research - How Do We Plan to Study 9 11 Exposures and Resulting Cancer Risk to WTC Workers.webm to reconstruct first responders' exposure to carcinogens during the September 11 attacks]]

In 1990, Boffetta moved to Lyon, France, to join the International Agency for Research on Cancer, IARC, first as medical officer until 1994 and later as chief of the Unit of Environmental Cancer Epidemiology (1995–2003). During this time he was also visiting scientist at the Division of Cancer Epidemiology and Genetics, US National Cancer Institute, in Washington (1998/99), foreign adjunct professor, at the Department of Medical Epidemiology and Microbiology and Tumour Biology Centre, Karolinska Institutet, Stockholm, Sweden (2000–2006).[http://ki.se/content/1/c6/02/28/99/get_pdf-15.php.pdf Newsletter MEP, KI]

In 2004 Boffetta moved back to IARC, Lyon to become group head and coordinator of the Genetics and Epidemiology Cluster.[http://epic.iarc.fr/centers/IARC/boffetta.html Biographical sketch of Paolo Boffetta at IARC] {{webarchive|url=https://web.archive.org/web/20100413040708/http://epic.iarc.fr/centers/IARC/boffetta.html |date=2010-04-13 }}

Between 2009 and 2020, he worked at Icahn School of Medicine at Mount Sinai as a professor.[http://www.mssm.edu/profiles/paolo-null-boffetta Contact details of Paolo Boffetta at the Mount Sinai School of Medicine] {{webarchive|url=https://web.archive.org/web/20101022154843/http://www.mssm.edu/profiles/paolo-null-boffetta |date=2010-10-22 }}

In 2020 he joined Stony Brook University, where he is a professor in the Department of Department of Family, Population & Preventive Medicine and associate director for population sciences at Stony Brook Cancer Center. Since 2018, he is a professor at the Department of Medical and Surgical Sciences of the University of Bologna.{{Cite web|url=https://www.unibo.it/sitoweb/paolo.boffetta|title=Paolo Boffetta — Università di Bologna — Home Page}}

He is an adjunct professor at the Department of Epidemiology, Harvard School of Public Health.[http://www.hsph.harvard.edu/faculty/paolo-boffetta/ Contact details of Paolo Boffetta at the Harvard School of Public Health] at the Department of Medicine, Vanderbilt University,[http://www.mc.vanderbilt.edu/reporter/index.html?ID=2298 Press release about new appointments at Vanderbilt University]

He was vice president of the International Prevention Research Institute in Lyon during 2009-2013.{{Cite web |url=http://www.i-pri.org/Faculty |title=Paolo Boffettas' biography on the website of International Prevention Research Institute |access-date=2010-10-18 |archive-url=https://web.archive.org/web/20101003191925/http://www.i-pri.org/Faculty |archive-date=2010-10-03 |url-status=dead }} He regularly serves as chair or member of national and international committees, including in particular review committees of the US National Institute of Health and the National Academy of Sciences. He is a fellow of the European Academy of Cancer Sciences and the New York Academy of Medicine.

Boffetta's specific field of research is the study of environmental factors for cancer.[https://web.archive.org/web/20110910065538/http://bmb.oxfordjournals.org/content/68/1/71.abstract Abstract of Contribution of environmental factors to cancer risk, Br Med Bull. 2003;68:71-94.] He always was very much interested in international collaboration why he was founding member and member of the executive committee of the several international research consortia, e.g. Interlymph – Non-Hodgkin's Lymphoma consortium (2001–08), the ILCCO – Lung cancer consortium (2003-), the INHANCE – Head and neck cancer consortium (2004-), the PANC4 – Pancreatic cancer consortium, the StoP Project – Stomach cancer, and the ILCEC - liver cancer consortium.

Boffetta is involved in several case-control studies of molecular epidemiology in different organs and countries around the world. Paolo Boffetta is a Member of the Steering Committee of the Asia Cohort Consortium (ACC)[http://www.asiacohort.org/SiteCollectionDocuments/October%202008%20Meeting.aspx General Membership Meeting Agenda, ACC] {{webarchive|url=https://web.archive.org/web/20110725015832/http://www.asiacohort.org/SiteCollectionDocuments/October%202008%20Meeting.aspx |date=2011-07-25 }} and was Chair of the Molecular Epidemiology Group (MEG) of the American Association for Cancer Research (AACR) (2008–2009).[http://www.aacr.org/home/scientists/meetings--workshops/special-conferences/previous-special-conferences/the-future-of-molecular-epidemiology/program.aspx Conference about the Future of Molecular Epidemiology, AACR]{{dead link|date=March 2018 |bot=InternetArchiveBot |fix-attempted=yes }}

He has been heavily involved in teaching activities during all his academic and research positions; e.g., at IARC he held the post of Director, IARC Course Programme (2000–2003 and 2004–2009). He was also Director of the IARC Fellowship Programme (2004–2009) and a Member of the UICC Fellowship Committee (2000–2009). He is currently teaching advanced epidemiology methods and cancer epidemiology at the Icahn School of Medicine at Mount Sinai, University of Bologna, and Harvard School of Public Health.

Boffetta's H-index is 157 (Web of Science) and 204 (Google Scholar).[https://www.ncbi.nlm.nih.gov/pubmed?term=boffetta,paolo&cmd=correctspelling Paolo Boffetta's publications] He is listed among the top 20 Italian scientists.{{Cite web|url=http://www.topitalianscientists.org/Top_italian_scientists_VIA-Academy.aspx|title = Top Italian Scientists Home}}

Boffetta has disclosed conflicts of interest on several scientific publications pertaining to a variety of hazards, including asbestos,{{cite journal |last1=Graziosi |first1=Francesca |last2=Caffaro |first2=Paola |last3=Bonetti |first3=Mattia |last4=Roccuzzo |first4=Francesco |last5=Rota |first5=Samantha |last6=Boffetta |first6=Paolo |title=Quantitative assessment of asbestos fibers in some normal and pathological extra-abdominal tissues-a scoping review |journal=J Occup Med Toxicol |date=2023 |volume=18 |issue=1 |page=24 |doi=10.1186/s12995-023-00392-4 |doi-access=free |pmid=37946239 |pmc=10634162 }} benzene,{{cite journal |last1=Sassano |first1=Michele |last2=Sadat Seyyedsalehi |first2=Monireh |last3=Boffetta |first3=Paolo |title=Occupational benzene exposure and colorectal cancer: A systematic review and meta-analysis |journal=Environ Res |date=2024 |volume=257 |doi=10.1016/j.envres.2024.119213 |pmid=38782339 |bibcode=2024ER....25719213S |url=https://pubmed.ncbi.nlm.nih.gov/38782339/ |access-date=6 October 2024|doi-access=free }} and arsenic.{{cite journal |last1=Sassano |first1=Michele |last2=Sadat Seyyedsalehi |first2=Monireh |last3=Cosmin Siea |first3=Andrei |last4=Boffetta |first4=Paolo |title=Occupational arsenic exposure and digestive and head and neck cancers: A systematic review and meta-analysis |journal=Environ Res |date=2024 |volume=260 |doi=10.1016/j.envres.2024.119643 |pmid=39053758 |bibcode=2024ER....26019643S |url=https://pubmed.ncbi.nlm.nih.gov/39053758/ |access-date=6 October 2024}}

In 2011, Boffetta disclosed funding from the Chlorine Chemistry Division of the American Chemistry Council on an epidemiological review investigating cancer risk associated with exposure to 2,3,7,8-Tetrachlorodibenzodioxin (TCDD),{{cite journal |last1=Boffetta |first1=Paolo |title=TCDD and cancer: A critical review of epidemiologic studies |journal=Crit Rev Toxicol |date=2011 |volume=41 |issue=7 |pages=622–636 |doi=10.3109/10408444.2011.560141 |pmid=21718216 |pmc=3154583 }} a contaminant in Agent Orange, an herbicide used in the Vietnam War.

In 2013, an investigative report published by Le Monde described controversies regarding Boffetta’s research career as a paid consultant.{{cite news |last1=Foucart |first1=Stephane |title=Epidémiologie: des liaisons dangereuses |url=https://www.lemonde.fr/sciences/article/2013/12/16/les-troubles-liaisons-d-un-epidemiologiste-italien_4335239_1650684.html |access-date=5 October 2024}} Boffetta was initially considered to be a candidate for the position of Director of France’s national center for research in epidemiology and public health, although upon scrutiny of his work as an industry consultant, including his co-founding of a Lyon-based scientific consulting firm receiving payments from industry, his candidacy was eventually withdrawn.

In 2024, Boffetta disclosed a financial relationship with the Arsenic Science Task Force, an industry group funding research on the health effects of arsenic,{{cite web |title=Comments on the Draft IRIS Toxicological Review of Inorganic Arsenic [CASRN 7440-38-2] |url=https://sab.epa.gov/ords/sab/r/sab_apex/sab/0?mm_id=6449&request=APPLICATION_PROCESS%3DMEETING_FILE&session=16950079336320 |publisher=EPA.gov}} to conduct an epidemiological review of arsenic exposure and the risk of head and neck cancer.

{{Reflist}}

• [http://ilcco.iarc.fr ILCCO homepage]
• [https://web.archive.org/web/20100322212758/http://inhance.iarc.fr/ INHANCE homepage]
• [http://epic.iarc.fr EPIC homepage]
• [http://www.fhcrc.org/science/acc/index.html ACC homepage]
• [http://www.uicc.org UICC homepage]

{{Authority control}}

{{DEFAULTSORT:Boffetta, Paolo}}

Category:1958 births

Category:Living people

Category:Cancer epidemiologists

Category:Columbia University Mailman School of Public Health alumni

Category:Heidelberg University alumni

Category:University of Turin alumni

Category:Vanderbilt University alumni

Category:University of Ottawa alumni

Category:Harvard T.H. Chan School of Public Health faculty

Category:Physicians from Turin

Category:Academic staff of the University of Bologna

Category:Italian expatriates in Germany